These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 25666092)

  • 1. A rapid bioluminescence assay for measuring myeloperoxidase activity in human plasma.
    Goiffon RJ; Martinez SC; Piwnica-Worms D
    Nat Commun; 2015 Feb; 6():6271. PubMed ID: 25666092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of a novel chemiluminescence enzyme immunoassay (CLEIA) with enzyme-linked immunosorbent assay (ELISA) for the determination of MPO-ANCA in patients with ANCA-associated vasculitis.
    Hirose O; Itabashi M; Takei T; Nitta K
    Mod Rheumatol; 2015 Mar; 25(2):230-4. PubMed ID: 25388618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New approaches to the measurement of the concentration and peroxidase activity of myeloperoxidase in human blood plasma].
    Gorudko IV; Cherkalina OS; Sokolov AV; Pulina MO; Zakharova ET; Vasil'ev VB; Cherenkevich SN; Panasenko OM
    Bioorg Khim; 2009; 35(5):629-39. PubMed ID: 19915640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determining myeloperoxidase activity and protein concentration in a single assay: Utility in biomarker and therapeutic studies.
    Russell M; Prokoph N; Henderson N; Eketjäll S; Balendran CA; Michaëlsson E; Fidock M; Hughes G
    J Immunol Methods; 2017 Oct; 449():76-79. PubMed ID: 28713008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A myeloperoxidase precursor, pro-myeloperoxidase, is present in human plasma and elevated in cardiovascular disease patients.
    Khalilova IS; Dickerhof N; Mocatta TJ; Bhagra CJ; McClean DR; Obinger C; Kettle AJ
    PLoS One; 2018; 13(3):e0192952. PubMed ID: 29590135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An immunological method to combine the measurement of active and total myeloperoxidase on the same biological fluid, and its application in finding inhibitors which interact directly with the enzyme.
    Franck T; Minguet G; Delporte C; Derochette S; Zouaoui Boudjeltia K; Van Antwerpen P; Gach O; Deby-Dupont G; Mouithys-Mickalad A; Serteyn D
    Free Radic Res; 2015 Jun; 49(6):790-9. PubMed ID: 25968947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myeloperoxidase and oxidation of uric acid in gout: implications for the clinical consequences of hyperuricaemia.
    Stamp LK; Turner R; Khalilova IS; Zhang M; Drake J; Forbes LV; Kettle AJ
    Rheumatology (Oxford); 2014 Nov; 53(11):1958-65. PubMed ID: 24899662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new easy method for specific measurement of active myeloperoxidase in human biological fluids and tissue extracts.
    Franck T; Kohnen S; Boudjeltia KZ; Van Antwerpen P; Bosseloir A; Niesten A; Gach O; Nys M; Deby-Dupont G; Serteyn D
    Talanta; 2009 Dec; 80(2):723-9. PubMed ID: 19836543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of myeloperoxidase in EDTA plasma: comparison of an enzyme-linked immunosorbent assay with a chemiluminescent automated immunoassay.
    Zelzer S; Khoschsorur G; Stettin M; Weihrauch G; Truschnig-Wilders M
    Clin Chim Acta; 2009 Aug; 406(1-2):62-5. PubMed ID: 19463803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of plasma myeloperoxidase in ESRD patients.
    Wang AY; Lam CW; Chan IH; Wang M; Lui SF; Sanderson JE
    Am J Kidney Dis; 2010 Nov; 56(5):937-46. PubMed ID: 20638167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development, optimization and validation of an absolute specific assay for active myeloperoxidase (MPO) and its application in a clinical context: role of MPO specific activity in coronary artery disease.
    Trentini A; Rosta V; Spadaro S; Bellini T; Rizzo P; Vieceli Dalla Sega F; Passaro A; Zuliani G; Gentili V; Campo G; Cervellati C
    Clin Chem Lab Med; 2020 Sep; 58(10):1749-1758. PubMed ID: 32031967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioluminescence imaging of myeloperoxidase activity in vivo.
    Gross S; Gammon ST; Moss BL; Rauch D; Harding J; Heinecke JW; Ratner L; Piwnica-Worms D
    Nat Med; 2009 Apr; 15(4):455-61. PubMed ID: 19305414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender-specific correlation between plasma myeloperoxidase levels and serum high-density lipoprotein-associated paraoxonase-1 levels in patients with stable and unstable coronary artery disease.
    Yunoki K; Naruko T; Inaba M; Inoue T; Nakagawa M; Sugioka K; Ohsawa M; Iwasa Y; Komatsu R; Itoh A; Haze K; Yoshiyama M; Becker AE; Ueda M
    Atherosclerosis; 2013 Dec; 231(2):308-14. PubMed ID: 24267244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A myeloperoxidase-specific assay based upon bromide-dependent chemiluminescence of luminol.
    Haqqani AS; Sandhu JK; Birnboim HC
    Anal Biochem; 1999 Aug; 273(1):126-32. PubMed ID: 10452808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of two consecutive fat-rich and carbohydrate-rich meals on postprandial myeloperoxidase response in women with and without type 2 diabetes mellitus.
    Schindhelm RK; Alssema M; Diamant M; Teerlink T; Dekker JM; Kok A; Kostense PJ; Nijpels G; Heine RJ; Scheffer PG
    Metabolism; 2008 Feb; 57(2):262-7. PubMed ID: 18191058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The free amino acid tyrosine enhances the chlorinating activity of human myeloperoxidase.
    Vlasova II; Sokolov AV; Arnhold J
    J Inorg Biochem; 2012 Jan; 106(1):76-83. PubMed ID: 22112843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophil myeloperoxidase measurements in plasma, laminar tissue, and skin of horses given black walnut extract.
    Riggs LM; Franck T; Moore JN; Krunkosky TM; Hurley DJ; Peroni JF; de la Rebière G; Serteyn DA
    Am J Vet Res; 2007 Jan; 68(1):81-6. PubMed ID: 17199423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased plasma soluble tumor necrosis factor receptor-1 and myeloperoxidase activity in patients with obstructive sleep apnea syndrome.
    Hanikoglu F; Huseyinoglu N; Ozben S; Cort A; Ozdem S; Ozben T
    Int J Neurosci; 2015; 125(9):655-62. PubMed ID: 25180986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual chronoamperometric detection of enzymatic biomarkers using magnetic beads and a low-cost flow cell.
    Moral-Vico J; Barallat J; Abad L; Olivé-Monllau R; Muñoz-Pascual FX; Galán Ortega A; del Campo FJ; Baldrich E
    Biosens Bioelectron; 2015 Jul; 69():328-36. PubMed ID: 25791338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of characteristics of natural autoantibodies against myeloperoxidase and anti-myeloperoxidase autoantibodies from patients with microscopic polyangiitis.
    Xu PC; Cui Z; Chen M; Hellmark T; Zhao MH
    Rheumatology (Oxford); 2011 Jul; 50(7):1236-43. PubMed ID: 21372002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.